Skip to main content
Equibles

NewEdge Advisors, LLC

Position in BOLT — Bolt Biotherapeutics, Inc.

CIK 1633516 NEW ORLEANS, LA
Back to BOLT Full portfolio

Position in BOLT

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$9,740
+$6,954 QoQ
Shares Held
2,530
+423.8% QoQ
Ownership
0.131%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 23 holders
Holding Since
Jun 2025
2 quarters on record
Voting authority Sole 5% Shared 0% None 95%

Common Shares in BOLT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NewEdge Advisors, LLC holds $47,765,473 across 103 Biotechnology names. BOLT ranks #62 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 18,435 $9,157,217
2 REGN
Regeneron Pharmaceuticals, Inc.
 11,911 $7,426,984
3 NUVB
Nuvation Bio Inc.
 1,231,733 $6,996,243
4 INCY
Incyte Corp
 34,605 $3,922,822
5 PHAT
Phathom Pharmaceuticals, Inc.
 203,962 $2,212,987
6 EXEL
Exelixis, Inc.
 32,532 $1,770,066
7 BMRN
Biomarin Pharmaceutical Inc
 27,287 $1,561,362
8 RPRX
Royalty Pharma plc
 21,597 $1,210,943

All Filings in BOLT

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,740 2,530
2025-06-30 $2,786 483